about
Effect of an isolated active compound (Cg-1) of Cassia glauca leaf on blood glucose, lipid profile, and atherogenic index in diabetic rats.Differential Telomere Shortening in Blood versus Arteries in an Animal Model of Type 2 Diabetes.Should we quantify insulin resistance in patients with renal disease?Reactive species and early manifestation of insulin resistance in type 2 diabetes.Disorders of glucose metabolism in the context of human immunodeficiency virus infection.Non-Association between rs7903146 and rs12255372 Polymorphisms in Transcription Factor 7-Like 2 Gene and Type 2 Diabetes Mellitus in Jahrom City, IranOxidative reactive species in cell injury: Mechanisms in diabetes mellitus and therapeutic approaches.Spontaneous type 2 diabetic rodent modelsNeuroprotective effects of D-Ala(2)GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model.Alterations of calcium channels and cell excitability in intracardiac ganglion neurons from type 2 diabetic ratsType 2 diabetes mellitus--current therapies and the emergence of surgical options.Proteomic analysis reveals downregulation of housekeeping proteins in the diabetic vascular proteome.Antidiabetic and Hypolipidemic Activities of Curculigo latifolia Fruit:Root Extract in High Fat Fed Diet and Low Dose STZ Induced Diabetic Rats.Anti-diabetic activity of methanolic extract of Alpinia galanga Linn. aerial parts in streptozotocin induced diabetic rats.Antidiabetic and Beta cell-protection activities of purple corn anthocyaninsProtective effect of Cassia glauca Linn. on the serum glucose and hepatic enzymes level in streptozotocin induced NIDDM in rats.Comparative proteome analysis of neural retinas from type 2 diabetic rats by two-dimensional electrophoresis.Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
P2860
Q33874050-1AC2B2F1-9E75-4D85-BAE0-F0CC58FC0572Q35983327-84DF51B9-E67E-4F2D-B49D-E891507969CAQ36341789-66B9E62B-8952-4015-BAD6-E4D09A3F5973Q36382700-9720FE3B-695D-4E85-AA46-C553A00D5463Q36405647-DCCAC1E5-821E-4403-834E-3AA903FAA2A8Q36418802-37D1A7A6-EB34-474D-AB85-8E383547650CQ36420078-8DAFDB07-5FFA-427B-AF91-5EFE250F34C4Q36825754-AA2434F9-B2E4-4C99-9CD7-44B7A0F4EC93Q36997912-59E205F2-FCC5-4F45-B835-68AC95A594D6Q37175715-03B42C5D-B27D-4766-9C89-8620942C4772Q37837496-EEE8890E-B6CD-4BA2-AAB3-A9A033F8E5ECQ39233717-D494D3BD-7F4A-4F5C-89D8-10EF295A0B0CQ41461751-5CCBD40D-9346-4291-9D4E-5EB442C9EE98Q41918435-575EFABC-A271-4C6C-88FB-FB228D0535A7Q42182656-4CBDE0DD-D108-427C-ACDA-8CEB6161BF11Q42911447-D15D1E8C-715D-48EE-AAEC-5BCC863629EFQ46929767-9B9CE168-496E-4714-AF33-458070E722B5Q49015193-49998901-2D92-400F-B5A1-43EBDF3BCF5C
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Treatment of insulin resistance in diabetes mellitus.
@ast
Treatment of insulin resistance in diabetes mellitus.
@en
type
label
Treatment of insulin resistance in diabetes mellitus.
@ast
Treatment of insulin resistance in diabetes mellitus.
@en
prefLabel
Treatment of insulin resistance in diabetes mellitus.
@ast
Treatment of insulin resistance in diabetes mellitus.
@en
P1476
Treatment of insulin resistance in diabetes mellitus.
@en
P2093
Harold E Lebovitz
Mary Ann Banerji
P304
P356
10.1016/J.EJPHAR.2004.02.051
P407
P577
2004-04-01T00:00:00Z